BDTX
Black Diamond Therapeutics, Inc.
+0.02 (+1.03%)1.96USD283K成交股數113M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00-100% | 0.00 | 0.00 | 0.00 | 70.0M | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 7.4M | 7.0M | 7.4M | 9.3M | 10.5M | 12.3M | 12.9M | 12.6M | 13.5M | 16.2M | 13.2M | 14.8M |
| 銷售管理費用 | 4.7M | 4.3M | 3.5M | 4.1M | 5.0M | 6.0M | 5.2M | 9.6M | 6.7M | 7.9M | 6.9M | 6.8M |
| 營業利益 | −12.1M-122% | −11.3M-38% | −11.0M-39% | −13.4M-39% | 54.5M-369% | −18.3M-24% | −18.1M-9% | −22.1M+3% | −20.2M | −24.0M | −20.0M | −21.6M |
| 營業利益率 | – | – | – | – | 77.9% | – | – | – | – | – | – | – |
| 稅後淨利 | −9.9M-118% | −9.0M-100% | −8.5M-45% | −10.6M-47% | 56.5M-410% | −69.6B+302514% | −15.6M-19% | −19.9M-5% | −18.2M | −23.0M | −19.2M | −20.9M |
| 淨利率 | – | – | – | – | 80.8% | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.17-117% | -0.16-43% | -0.15-46% | -0.19-47% | 0.98-380% | -0.28-38% | -0.28-46% | -0.36-37% | -0.35 | -0.45 | -0.52 | -0.57 |
| 稀釋股數 | 57.4M | 57.2M | 56.9M | 56.8M | 57.7M | 55.0M | 56.5M | 55.2M | 51.8M | 50.9M | 36.5M | 36.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 19.2M | 30.1M | 30.9M | 30.0M | 98.4M | 36.4M | 23.4M | 32.8M | 25.4M | 58.0M | 41.9M | 39.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 125M | 133M | 158M | 166M | 176M | 123M | 138M | 150M | 143M | 172M | 120M | 136M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 28.9M | 28.6M | 31.6M | 33.8M | 34.7M | 39.4M | 40.5M | 39.0M | 38.2M | 38.1M | 37.7M | 37.4M |
| 股東權益 | 96.1M | 104M | 126M | 133M | 142M | 83.3M | 97.4M | 111M | 104M | 134M | 82.2M | 98.2M |
| 負債比 | 23.1% | 21.5% | 20.0% | 20.3% | 19.7% | 32.1% | 29.3% | 26.0% | 26.8% | 22.1% | 31.4% | 27.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −10.2M | – | – | 53.4M-352% | – | – | – | −21.2M | – | – | −20.0M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 0.00 |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −20.0M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 70.0M
| Reportable | 70.0M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 70.0M | – | 22.4B | 31,952.9% | 0.39 | – |
| FY2024 | 0.00 | – | −69.7B | –% | -1.27 | −62.3M |
| FY2023 | – | – | −82.4M | –% | -1.88 | −66.8M |
| FY2022 | – | – | −91.2M | –% | -2.52 | −85.3M |
| FY2021 | – | – | −126M | –% | -3.47 | −103M |
| FY2020 | 0.00 | – | −67.3M | –% | -2.05 | −52.3M |
| FY2019 | 0.00 | – | −35.3M | –% | -16.99 | −24.7M |
| FY2018 | 0.00 | – | −8.9M | –% | -4.42 | −8.5M |